Holding · 0.9% · hold (from 0.9%) · mega · Technology · last 230.10
Entry 222.00–236.00 · Stop 205.00 · Target 293.00 · Hold (on target)
Long thesis (conviction 55): oversold, with net cash (F-LRCX-5, F-LRCX-7); China export risk (F-LRCX-4) and the semiconductor total argue against adding.
Thesis (long, position, conviction 55)
Bull: Lam just posted 54.4% YoY revenue growth to $8.22B with a 52.3% gross margin and 40% GAAP operating margin (F-LRCX-1, F-LRCX-3), funding itself easily with $3.5B operating cash flow against only $258M capex (F-LRCX-6) and a net cash position ($7.45B cash vs $3.73B long-term debt, F-LRCX-5). EPS of $2.19-2.20 came in only fractionally below estimate (-0.97% surprise, F-LRCX-9) — this was not a fundamental miss. Sell-side remains overwhelmingly bullish: 35 of 40 ratings are buy/strong buy with zero sells (F-LRCX-10). Yet the stock is 46.8% off its 52-week high, down 21% over three months, trading far below its 20/50/200-day moving averages, and RSI14 is 24.6 (F-LRCX-7, F-LRCX-8) — a severe technical oversold condition that is disconnected from the actual earnings quality. This combination of strong, growing profitability, net cash, and near-unanimous analyst support against a capitulation-level price washout is the classic setup for a mean-reversion long in a quality semicap name.
Bear: The 3-month relative strength vs SPY is -24.1% (F-LRCX-8), meaning this is not just market beta — something specific is weighing on sentiment, likely China/export-control risk given 35% of revenue comes from China customer facilities (F-LRCX-4) and the 10-Q explicitly flags export controls and trade regulation as risks to sales (F-LRCX-11). Oversold RSI in a strong downtrend (price below all three moving averages) can stay oversold or keep falling — RSI14 at 24.6 is not a reliable standalone bottom signal in semicap cycles, which are famously volatile around capex digestion and export-rule headlines. There is no confirmed near-term catalyst to force a re-rating; the next earnings date (2027-01-26) is an estimate, not a confirmed company date, leaving a multi-month window where sentiment-driven selling could continue unchecked.
Valuation: The brief has no explicit P/E or FCF yield figure, but using diluted EPS of $2.19 for the quarter (~$8.76 run-rate annualized if growth holds) against a $230 price implies a forward-looking earnings multiple in the high-teens to low-20s — reasonable to cheap for a company growing revenue 54% YoY with 40% operating margins and net cash, if that growth rate is remotely sustainable. The stock's 46.8% drawdown from its 52-week high looks disproportionate to the fundamental trajectory shown in this quarter's results, suggesting the market is pricing in a sharp deceleration or China-related disruption that has not yet shown up in the reported financials.
Catalysts
2027-01-26: Estimated FQ2'27 earnings release, consensus EPS ~$2.37 on ~$8.75B revenue (date not company-confirmed)
undated: Any news flow on China export-control enforcement, given 35% of revenue is China-facility-attributed
undated: Technical: RSI14 mean-reversion from oversold 24.6 level and price reclaiming 50-day MA (~$302)
Facts
F-LRCX-1: Revenue for the quarter ended September 27, 2026 was $8.219 billion, up 54.4% from $5.324 billion in the year-earlier quarter. (as of 2026-10-22)[E7299]source
F-LRCX-2: GAAP operating income for the quarter ended September 27, 2026 was $3.284 billion, compared with $1.829 billion in the year-earlier quarter. (as of 2026-10-22)[E7299]source
F-LRCX-3: For the quarter ended September 27, 2026, GAAP gross margin was 52.3%, operating margin was 40.0%, and diluted EPS was $2.19. (as of 2026-10-21)[E7305]source
F-LRCX-4: Revenue attributed to customer facilities in China was $2.886 billion, about 35% of total revenue, for the quarter ended September 27, 2026. (as of 2026-10-22)[E7307]source
F-LRCX-5: Cash, cash equivalents, and restricted cash totaled $7.451 billion at September 27, 2026; long-term debt and finance lease obligations totaled $3.732 billion. (as of 2026-10-22)[E7305, E7306]sourcesource
F-LRCX-6: Operating cash flow was $3.498 billion and capital expenditures and intangible asset purchases were $257.7 million for the quarter ended September 27, 2026. (as of 2026-10-22)[E7306]source
F-LRCX-7: LRCX closed at $230.10 on October 23, 2026, 46.8% below its 52-week closing high; the close was below its 20-, 50-, and 200-day moving averages, and RSI14 was 24.6. (as of 2026-10-23)[E7005]
F-LRCX-8: LRCX’s three-month return through October 23, 2026 was -21.0%, and its three-month relative strength versus SPY was -24.1%. (as of 2026-10-23)[E7005]
F-LRCX-9: Diluted EPS for the latest reported quarter was $2.20 versus an analyst estimate of $2.2215, a reported surprise of -0.97%. (as of 2026-10-23)[E7030]
F-LRCX-10: In October 2026, analysts’ recommendations tallied 10 strong buy, 25 buy, 5 hold, and no sell or strong-sell ratings. (as of 2026-10-23)[E7030]
F-LRCX-11: Lam’s October 22, 2026 10-Q identifies supply-chain disruptions, manufacturing-capacity constraints, trade regulations, and export controls as risks that could affect operations or sales. (as of 2026-10-22)[E7299]source
What would change the view
A close below $205 would invalidate the oversold-bounce thesis and suggest further technical deterioration
News of expanded export restrictions specifically targeting Lam's China customer base would materially raise bear case risk
Next earnings report (whenever confirmed) showing gross margin compression below ~48% or revenue guidance cut would undermine the fundamental support for this long
A sustained RSI reading below 30 for multiple additional weeks without price stabilization would argue the downtrend, not mean reversion, is dominant
Data quality
Quality score 100/100.
Gap: The quote block is timestamped October 24, 2026, after the context date of October 23; the reported price and trend facts use the daily-bar close dated October 23.
Gap: The context earnings data has no date in the next 90 days, while a separate calendar lists January 26, 2027; treat that date as an estimate rather than a confirmed company-announced date.
Red flag: The company identifies supply-chain disruptions, manufacturing-capacity constraints, trade rules, and export controls as risks to operations or sales. Evidence: E7299.
Red flag: LRCX’s three-month relative strength versus SPY was -24.1% through October 23, 2026. Evidence: E7005.